| Entry |
|
|---|
| Name |
Trifluridine (JAN/USP/INN);
Viroptic (TN) |
|---|
| Abbr |
TFT |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C10H11F3N2O5
|
|---|
| Exact mass |
296.0620
|
|---|
| Mol weight |
296.20
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Product (mixture): | D10526<JP/US> |
|
|---|
| Efficacy |
Antiviral, Nucleic acid biosynthesis inhibitor |
|---|
| Disease |
Keratitis due to herpes simplex virus [DS: H00365] |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AD Antivirals
S01AD02 Trifluridine
D00391 Trifluridine (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Antivirals
Antiherpetic Agents
Trifluridine
D00391 Trifluridine (JAN/USP/INN)
Ophthalmic Agents
Ophthalmic Anti-Infectives
Antiviral, Ophthalmic
Trifluridine
D00391 Trifluridine (JAN/USP/INN)
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
Herpesvirus DNA polymerase inhibitor
D00391 Trifluridine (JAN/USP/INN) <US>
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
Herpesvirus DNA polymerase inhibitor
D00391 Trifluridine (JAN/USP/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C1y C 18.6900 -19.3200
2 C1x C 20.0200 -19.3200
3 C1y C 20.4400 -18.0600
4 O2x O 19.3900 -17.2200
5 C1y C 18.2700 -18.0600
6 O1a O 17.9200 -20.4400
7 C1b C 17.0100 -17.6400
8 O1a O 16.0300 -18.5500
9 N4y N 21.7700 -17.6400
10 C8x C 21.7700 -16.2400
11 C8y C 22.9600 -18.3400
12 N4x N 24.2200 -17.6400
13 C8y C 24.2200 -16.2400
14 C8y C 22.9600 -15.5400
15 C1d C 22.9600 -14.1400
16 O5x O 25.4100 -15.5400
17 O5x O 22.9600 -19.7400
18 X F 22.9600 -12.7400
19 X F 21.5600 -14.1400
20 X F 24.3600 -14.1400
BOND 21
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 1 6 1 #Down
7 5 7 1 #Up
8 7 8 1
9 3 9 1 #Up
10 10 9 1
11 11 12 1
12 12 13 1
13 13 14 1
14 10 14 2
15 14 15 1
16 13 16 2
17 11 17 2
18 15 18 1
19 15 19 1
20 15 20 1
21 11 9 1
|
|---|
